{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:15:28Z","timestamp":1785885328356,"version":"3.56.0"},"reference-count":50,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,4]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Visceral leishmaniasis (VL) is a parasitic disease with an estimated 30\u2009000 new cases occurring annually. There is an observed variation in the efficacy of the current first-line therapies across different regions. Such heterogeneity could be a function of host, parasite and drug factors. An individual participant data meta-analysis (IPD-MA) is planned to explore the determinants of treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Infectious Diseases Data Observatory (IDDO) VL living systematic review (IDDO VL LSR) library is an open-access resource of all published therapeutic studies in VL since 1980. For this current review, the search includes all clinical trials published between 1 January 1980 and 2 May 2021. Studies indexed in the IDDO VL LSR library were screened for eligibility for inclusion in this IPD-MA. Corresponding authors and principal investigators of the studies meeting the eligibility criteria for inclusion were invited to be part of the collaborative IPD-MA. Authors agreeing to participate in this collaborative research were requested to share the IPD using the IDDO VL data platform. The IDDO VL data platform currently holds data sets from clinical trials standardised to a common data format and provides a unique opportunity to identify host, parasite and drug determinants of treatment outcomes. Multivariable regression models will be constructed to identify determinants of therapeutic outcomes using generalised linear mixed-effects models accounting for within-study site clustering.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This IPD-MA meets the criteria for waiver of ethical review as defined by the Oxford Tropical Research Ethics Committee (OxTREC) granted to IDDO, as the research consists of secondary analysis of existing anonymised data (Exempt granted on 29 March 2023, OxTREC REF: IDDO) Ethics approval was granted by the ICMR-Rajendra Memorial Research Institute of Medical Sciences ethics committee (Letter no: RMRI\/EC\/30\/2022) on 04-07-2022. The results of this IPD-MA will be disseminated at conferences, IDDO website and any peer-reviewed publications. All publications will be open source. Findings of this research will be critically important for the control programmes at regional\/global levels, policy makers and groups developing new VL treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration<\/jats:title>\n                    <jats:p>CRD42021284622.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-074679","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T12:45:28Z","timestamp":1698497128000},"page":"e074679","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-4683","authenticated-orcid":false,"given":"Rishikesh","family":"Kumar","sequence":"first","affiliation":[{"name":"Indian Council of Medical Research (ICMR)\u2013Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-846X","authenticated-orcid":false,"given":"Prabin","family":"Dahal","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-3053","authenticated-orcid":false,"given":"Sauman","family":"Singh-Phulgenda","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyamat Ali","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research (ICMR)\u2013Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-0154","authenticated-orcid":false,"given":"Abdalla","family":"Munir","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Naylor","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-4928","authenticated-orcid":false,"given":"James","family":"Wilson","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Buck","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Rahi","sequence":"additional","affiliation":[{"name":"Epidemiology and Communicable Diseases, Indian Council of Medical Research (ICMR), New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paritosh","family":"Malaviya","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Laboratory, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Disease Initiative, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Laboratory, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Ritmeijer","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Infectious Diseases Data Observatory (IDDO), University of Oxford, Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-2458","authenticated-orcid":false,"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research (ICMR)\u2013Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"2025121512353562000_13.10.e074679.1","doi-asserted-by":"crossref","unstructured":"Boelaert M , Sundar S . Leishmaniasis. In: Farrar J , Hotez PJ , Junghanss T , et al ., eds. Manson\u2019s Tropical Infectious Diseases. Twentry-third edition. Elsevier Health Sciences, 2014: 631\u201351. doi:10.1016\/B978-0-7020-5101-2.00048-0","DOI":"10.1016\/B978-0-7020-5101-2.00048-0"},{"key":"2025121512353562000_13.10.e074679.2","unstructured":"World Health Organization. Leishmaniasis . 2023. Available: https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1"},{"key":"2025121512353562000_13.10.e074679.3","doi-asserted-by":"publisher","DOI":"10.1086\/381203"},{"key":"2025121512353562000_13.10.e074679.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1743-7","article-title":"A review of visceral Leishmaniasis during the conflict in South Sudan and the consequences for East African countries","volume":"9","author":"Al-Salem","year":"2016","journal-title":"Parasites Vectors"},{"key":"2025121512353562000_13.10.e074679.5","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral Leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2025121512353562000_13.10.e074679.6","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182017002116"},{"key":"2025121512353562000_13.10.e074679.7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.1.111-126.2006"},{"key":"2025121512353562000_13.10.e074679.8","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.62886"},{"key":"2025121512353562000_13.10.e074679.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003820","article-title":"Ex vivo host and parasite response to Antileishmanial drugs and immunomodulators","volume":"9","author":"Gonzalez-Fajardo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in Leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000705","article-title":"Visceral Leishmaniasis relapse in Southern Sudan (1999-2007): A retrospective study of risk factors and trends","volume":"4","author":"Gorski","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral Leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002536","article-title":"Risk factors for visceral Leishmaniasis relapse in immunocompetent patients following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100220","article-title":"Failure of Miltefosine treatment for visceral Leishmaniasis in children and men in South-East Asia","volume":"9","author":"Ostyn","year":"2014","journal-title":"PLoS One"},{"key":"2025121512353562000_13.10.e074679.15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.19-0179","article-title":"Effectiveness of single-dose liposomal amphotericin B in visceral Leishmaniasis in Bihar","volume":"101","author":"Sundar","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"2025121512353562000_13.10.e074679.16","doi-asserted-by":"crossref","first-page":"100487","DOI":"10.1016\/j.xcrm.2021.100487","article-title":"Immunological factors, but not clinical features, predict visceral Leishmaniasis relapse in patients Co-infected with HIV","volume":"3","author":"Takele","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"2025121512353562000_13.10.e074679.17","doi-asserted-by":"crossref","unstructured":"Chhajed R , Dahal P , Singh-Phulgenda S , et al . Estimating the proportion of relapse following treatment of visceral Leishmaniasis: meta-analysis using infectious diseases data Observatory (Iddo) living systematic review. SSRN [Preprint] 2023. doi:10.2139\/ssrn.4464863","DOI":"10.2139\/ssrn.4464863"},{"key":"2025121512353562000_13.10.e074679.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"2025121512353562000_13.10.e074679.19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit102"},{"key":"2025121512353562000_13.10.e074679.20","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0259"},{"key":"2025121512353562000_13.10.e074679.21","doi-asserted-by":"crossref","unstructured":"Singh-Phulgenda S , Rashan S , Harriss E , et al . n.d. Infectious diseases data Observatory (IDDO) visceral Leishmaniasis library of clinical therapeutic studies: A protocol for a living systematic review of clinical studies. Wellcome Open Res;7:155. doi:10.12688\/wellcomeopenres.17739.1","DOI":"10.12688\/wellcomeopenres.17739.1"},{"key":"2025121512353562000_13.10.e074679.22","unstructured":"Infectious Diseases Data Observatory . Visceral Leishmaniasis data inventory. 2023. Available: https:\/\/www.iddo.org\/document\/visceral-leishmaniasis-data-inventory"},{"key":"2025121512353562000_13.10.e074679.23","unstructured":"Infectious Diseases Data Observatory . New global collaboration developing standards for standardised data collection across the VL research community. 2020. Available: https:\/\/www.iddo.org\/news\/new-global-collaboration-developing-standards-standardised-data-collection-across-vl-research [Accessed 28 Feb 2023]."},{"key":"2025121512353562000_13.10.e074679.24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1983.32.475","article-title":"Quantitation of Amastigotes of Leishmania Donovani in Smears of splenic Aspirates from patients with visceral Leishmaniasis","volume":"32","author":"Chulay","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"2025121512353562000_13.10.e074679.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2010.09.006"},{"key":"2025121512353562000_13.10.e074679.26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr185"},{"key":"2025121512353562000_13.10.e074679.27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40291-018-0343-y","article-title":"Molecular diagnosis of visceral Leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"2025121512353562000_13.10.e074679.28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu039"},{"key":"2025121512353562000_13.10.e074679.29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7141"},{"key":"2025121512353562000_13.10.e074679.30","doi-asserted-by":"crossref","unstructured":"Riley RD , Moons KGM , Debray TPA . IPD Meta\u2010Analysis for Prognostic factor research. In: Riley RD , LAS JFT , eds. Individual Participant Data Meta-Analysis. A Handbook for Healthcare Research. John Wiley & Sons Ltd, 2021: 421\u201345. doi:10.1002\/9781119333784","DOI":"10.1002\/9781119333784.ch16"},{"key":"2025121512353562000_13.10.e074679.31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection \u2013 A review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"},{"key":"2025121512353562000_13.10.e074679.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3148"},{"key":"2025121512353562000_13.10.e074679.33","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025121512353562000_13.10.e074679.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009302","article-title":"Serious adverse events following treatment of visceral Leishmaniasis: A systematic review and meta-analysis","volume":"15","author":"Singh-Phulgenda","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.35","unstructured":"World Health Organization . Geneva, Switzerland. 2022."},{"key":"2025121512353562000_13.10.e074679.36","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8516"},{"key":"2025121512353562000_13.10.e074679.37","unstructured":"Team RC . R: A language and environment for statistical computing. Vienna, Austria, 2021. Available: https:\/\/www.r-project.org"},{"key":"2025121512353562000_13.10.e074679.38","unstructured":"Stata statistical software: release 17. College Station, TX 2021."},{"key":"2025121512353562000_13.10.e074679.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025121512353562000_13.10.e074679.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2025121512353562000_13.10.e074679.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3656"},{"key":"2025121512353562000_13.10.e074679.42","unstructured":"Infectious Diseases Data Observatory. Visceral leishmaniasis research agenda, . 2019 Available: https:\/\/www.iddo.org\/vl\/research\/research-agenda"},{"key":"2025121512353562000_13.10.e074679.43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k5224","article-title":"Eliminating visceral Leishmaniasis in South Asia: the road ahead","volume":"364","author":"Rijal","year":"2019","journal-title":"BMJ"},{"key":"2025121512353562000_13.10.e074679.44","unstructured":"World Health Organization . Regional Strategic Framework for Elimination of Kala-azar from the South-East Asia Region: 2022-2026. New Delhi: World Health Organization, 2022."},{"key":"2025121512353562000_13.10.e074679.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010696","article-title":"The increasing incidence of visceral Leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018","volume":"16","author":"Naylor-Leyland","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2025121512353562000_13.10.e074679.46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu333"},{"key":"2025121512353562000_13.10.e074679.47","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00061-07"},{"key":"2025121512353562000_13.10.e074679.48","doi-asserted-by":"crossref","first-page":"604117","DOI":"10.3389\/fcimb.2021.604117","article-title":"Visceral Leishmaniasis-HIV Coinfection as a Predictor of increased Leishmania transmission at the village level in Bihar, India","volume":"11","author":"Cloots","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2025121512353562000_13.10.e074679.49","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.12688\/f1000research.9218.1","article-title":"Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance","volume":"5","author":"Laffitte","year":"2022","journal-title":"F1000Res"},{"key":"2025121512353562000_13.10.e074679.50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in Leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front Trop Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-074679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:35:50Z","timestamp":1765830950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-074679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,28]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-074679"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-074679","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}